| AEMD Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the AEMD shares outstanding history going back to 4/14/2015:
Also see: AEMD Market Cap History AEMD YTD Return |
AEMD Shares Outstanding History — Aethlon Medical Share Count Over Time
As of 6/8/2026 Aethlon Medical has 474112 AEMD shares outstanding. Investors often track the AEMD shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows AEMD share count trends over time, with 48 historical shares outstanding datapoints presented, dating back to 4/14/2015.
| AEMD Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AEMD Historical Shares Outstanding: +111.69% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AEMD Stock Price Chart |
| About Aethlon Medical Inc |
| Aethlon Medical, Inc. is a medical therapeutic company which develop the Hemopurifier, an immunotherapeutic device aimed at treating cancer, life-threatening viral infections, and aiding in organ transplantation. Pre-clinical studies show it can remove harmful exosomes from biological fluids using lectin-based technology. The FDA has designated it as a Breakthrough Device for advanced or metastatic cancer unresponsive to standard therapies and for treating life-threatening viruses not addressed by approved therapies, with an open Investigational Device Exemption. We show 48 historical shares outstanding datapoints in our coverage of AEMD's shares outstanding history. Understanding the changing numbers of AEMD shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like AEMD versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching AEMD by allowing them to research AEMD shares outstanding history as well as any other stock in our coverage universe. |
| AEMD Current Stock Quote |
Quotes delayed 20 minutes  Free AEMD Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| AEMD Share Performance |
| Shares Outstanding Peers |
| Aethlon Medical (AEMD) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
AERI Shares Outstanding History AEZS Shares Outstanding History AFIB Shares Outstanding History AGEN Shares Outstanding History AGIO Shares Outstanding History AGL Shares Outstanding History AGLE Shares Outstanding History AGN Shares Outstanding History AGPU Shares Outstanding History AGRX Shares Outstanding History More Healthcare companies » |
AEMD Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
